Jones Trading Initiates Coverage On KalVista Pharma with Buy Rating, Announces Price Target of $35
Portfolio Pulse from Benzinga Newsdesk
Jones Trading has initiated coverage on KalVista Pharma with a Buy rating and set a price target of $35.
September 27, 2024 | 1:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jones Trading has initiated coverage on KalVista Pharma with a Buy rating and a price target of $35, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $35 by Jones Trading suggests a positive sentiment towards KalVista Pharma's stock. This is likely to attract investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100